SCHEMBL845382

SCHEMBL845382

CC(Oc1cccc(Cl)c1)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)C(C)Oc3cccc(Cl)c3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 5/20 0.52
CREBBP Q92793 5/20 0.52
TSHR P16473 1/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
POLB P06746 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
KCNH2 Q12809 1/20 0.45
NPSR1 Q6W5P4 2/20 0.45
PABPC1 P11940 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844903 0.82 EP300 (0.51) EP300CREBBPTSHRALDH1A1MAPK1
SCHEMBL2193086 0.82 EP300 (0.46) EP300CREBBPTSHRALDH1A1MAPK1
SCHEMBL873777 0.80 EP300 (0.49) EP300CREBBPTSHRALDH1A1CYP2C19
SCHEMBL844890 0.80 KCNH2 (0.51) TSHRALDH1A1MAPK1HTTCYP2C9
SCHEMBL845488 0.77 CYP2C19 (0.48) TSHRALDH1A1MAPK1HTTCYP2C9
SCHEMBL845202 0.77 CYP2C19 (0.48) TSHRALDH1A1MAPK1HTTCYP2C9
SCHEMBL845759 0.77 CYP2C19 (0.48) TSHRALDH1A1MAPK1HTTCYP2C9
SCHEMBL10120083 0.75 CPT2 (0.46) EP300CREBBPTSHRALDH1A1PABPC1
SCHEMBL28826383 0.75 OGG1 (0.46) TSHRALDH1A1KMT2AL3MBTL1
SCHEMBL844894 0.75 CYP2C19 (0.55) TSHRALDH1A1MAPK1HTTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed